Triall Insights.
22 May 2023, 11:19
Triall Insights š
According to a BMJ study that analysed 225 Phase 3 clinical trials, the median estimated cost per patient for a study amounted to $42,413.
Costs were highest for drugs that required comparison with an already approved & effective drug and lowest for those where the FDA waived the requirements for a control group.
Source: bmjopen.bmj.com/content/10/6/e038863.full
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help spread the news on Twitter:
#blockchainforhealth #TRL
Same news in other sources
122 May 2023, 11:19
Triall Insights š
According to a BMJ study that analysed 225 Phase 3 clinical trials, the median estimated cost per patient for a study amounted to $42,413.
Costs were highest for drugs that required comparison with an already approved & effective drug and lowest for those where the FDA waived the requirements for a control group.
Source: bmjopen.bmj.com/content/10/6/e038863.full
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help spread the news on Twitter:
#blockchainforhealth #TRL
Triall Insights.
Triall Insights š
According to a BMJ study that analysed 225 Phase 3 clinical trials, the median estimated cost per patient for a study amounted to $42,413.
Costs were highest for drugs that required comparison with an already approved & effective drug and lowest for those where the FDA waived the requirements for a control group.
Source: bmjopen.bmj.com/content/10/6/e038863.full
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1660605909431713792?s=20
#blockchainforhealth #TRL